Market revenue in 2023 | USD 306.4 million |
Market revenue in 2030 | USD 427.2 million |
Growth rate | 4.9% (CAGR from 2023 to 2030) |
Largest segment | Polyphenylsulfone (ppsu) |
Fastest growing segment | Polypropylene (PP) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Polycarbonate (PC), Liquid Crystal Polymer (LCP), Polyphenylsulfone (PPSU), Polyethersulfone (PES), Polyethylenimine (PEI), Polymethyl Methacrylate (PMMA) |
Key market players worldwide | Röchling Group, Nolato AB Class B, Compagnie de Saint-Gobain SA, SABIC, Orthoplastics, Eastman Chemical Co, Celanese Corp Class A, Dow Inc, Tekni-Plex, Solvay SA, Hmc Polymers Company, Integer Holdings Corp, Trelleborg AB ADR, Avantor Inc, Trinseo PLC, Evonik Industries AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical plastic market will help companies and investors design strategic landscapes.
Polyphenylsulfone (ppsu) was the largest segment with a revenue share of 34.2% in 2023. Horizon Databook has segmented the Saudi Arabia medical plastic market based on polyethylene (pe), polypropylene (pp), polycarbonate (pc), liquid crystal polymer (lcp), polyphenylsulfone (ppsu), polyethersulfone (pes), polyethylenimine (pei), polymethyl methacrylate (pmma) covering the revenue growth of each sub-segment from 2018 to 2030.
The government of Saudi Arabia is carrying out agreements with major healthcare sector players to boost the healthcare sector in the country. In January 2022, the Saudi Ministry of Investment signed a contract with GlaxoSmithKline plc, a company based in the pharmaceutical and healthcare sector.
The government plans to localize manufacturing and transfer knowledge and technology to transform Saudi Arabia into a regional hub for research in the medical self-care industry.
Lifera is a contract development and manufacturing organization (CDMO) that collaborates with local pharmaceutical manufacturers to develop plasma therapeutics, vaccines, insulins, and cell and gene therapies.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia medical plastic market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia medical plastic market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account